Sonographic Assessment of Splenic Manifestations in Sickle Cell Disease Patients and Its Relation to Hematological Parameters: A Cross-Sectional Study in Basra, Iraq

Background Hemoglobinopathies, such as sickle cell disease (SCD), are inherited disorders of hemoglobin (Hb) synthesis. SCD presents with complex clinical manifestations, including anemia, painful episodes, and organ damage due to recurrent vaso-occlusion. The spleen is one of the first organs affec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2024-10, Vol.16 (10), p.e72322
Hauptverfasser: Sadeq, Hussein S, Abdulkareem, Amenah S, Dawood, Qutaiba M, Khalaf, Asaad A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Hemoglobinopathies, such as sickle cell disease (SCD), are inherited disorders of hemoglobin (Hb) synthesis. SCD presents with complex clinical manifestations, including anemia, painful episodes, and organ damage due to recurrent vaso-occlusion. The spleen is one of the first organs affected in SCD patients, with hyposplenism typically occurring by age five. However, older patients may show variations in splenic size, which can complicate the diagnosis. Objective This study aimed to investigate the radiological manifestations of the spleen in patients with SCD using sonographic assessment and the relationship between these manifestations and the patient's clinical and laboratory findings. Methodology This descriptive cross-sectional study was carried out at the Basra Hematology Center, which is the largest center for hematological diseases in the southern part of Iraq. It was carried out over a three-month period from May 22 to August 22, 2024. A total of 81 patients aged 15 and above, diagnosed with SCD, and attending the outpatient clinic at Basra Hematology Center in Basra city were included. Participants were identified through medical records and referrals from private outpatient clinics. Inclusion criteria ensured participants had a confirmed SCD diagnosis and met the age requirements. Exclusion criteria eliminated individuals with sickle cell trait, other hemolytic anemias, leukemia, relevant co-morbidities, or those who declined participation. After obtaining informed consent, each patient was interviewed by the research team, their blood was taken for lab tests, and then an ultrasound scan of their spleen was performed. Results Regarding the demographic characteristics of patients, age showed a statistically significant difference across the groups (p=0.017), indicating that marked splenomegaly is associated with younger individuals (mean age of 19.50 ± 4.95 years) compared to autosplenectomy, which is linked to older patients (mean age of 35.42 ± 11.84 years). Regarding radiological findings, splenic size was categorized into normal size, splenomegaly, small spleen, and autosplenectomy. Increased echogenicity is more frequently seen in the small spleen group (87.5%, p
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.72322